Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 22, Pages -Publisher
MDPI
DOI: 10.3390/ijms242216131
Keywords
metformin; hydrogen sulfide; hybrid drugs; H2S donor; isothiocyanate
Ask authors/readers for more resources
Metformin, a first-line therapy for type 2 diabetes, has also been evaluated as an anti-cancer agent. Hydrogen sulfide and H2S donors have shown anti-cancer effects, and isothiocyanates have the additional ability to inhibit histone deacetylase enzymes. A new hybrid molecule, Met-ITC, has been designed to release both Met and H2S and has demonstrated higher efficacy in inhibiting cancer cells and affecting the cell cycle compared to Met.
Metformin (Met) is the first-line therapy in type 2 diabetes mellitus but, in last few years, it has also been evaluated as anti-cancer agent. Several pathways, such as AMPK or PI3K/Akt/mTOR, are likely to be involved in the anti-cancer Met activity. In addition, hydrogen sulfide (H2S) and H2S donors have been described as anti-cancer agents affecting cell-cycle and inducing apoptosis. Among H2S donors, isothiocyanates are endowed with a further anti-cancer mechanism: the inhibition of the histone deacetylase enzymes. On this basis, a hybrid molecule (Met-ITC) obtained through the addition of an isothiocyanate moiety to the Met molecule was designed and its ability to release Met has been demonstrated. Met-ITC exhibited more efficacy and potency than Met in inhibiting cancer cells (AsPC-1, MIA PaCa-2, MCF-7) viability and it was less effective on non-tumorigenic cells (MCF 10-A). The ability of Met-ITC to release H2S has been recorded both in cell-free and in cancer cells assays. Finally, its ability to affect the cell cycle and to induce both early and late apoptosis has been demonstrated on the most sensitive cell line (MCF-7). These results confirmed that Met-ITC is a new hybrid molecule endowed with potential anti-cancer properties derived both from Met and H2S.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available